Complex Neurobiological Mechanisms and Risk Factors Underlying Late-Life Depression

Late-life depression (LLD) is a prevalent and debilitating disease closely associated with cognitive decline, exacerbation of chronic medical illness, decreased quality of life, and increased societal burden. This review explores the complex neurobiological mechanisms and key risk factors underlying LLD. Inflammation, particularly involving cytokines such as IL-6 and TNF-α and the activation of the NLRP3 inflammasome, plays a central role. Genetic vulnerability, including polymorphisms in serotonin-transporter-linked polymorphic region (5-HTTLPR), BDNF Val66Met, and methylenetetrahydrofolate reductase (MTHFR), interacts with environmental stressors to increase susceptibility. Dysregulation of neurotransmitters such as serotonin, dopamine, norepinephrine, glutamate, and GABA contributes to core depressive symptoms. LLD is also characterized by functional disruptions in large-scale brain networks and structural changes including cortical thinning and hippocampal atrophy. Additionally, HPA (hypothalamic-pituitary-adrenal) axis hyperactivity, gut microbiota dysbiosis, and metabolic disorders such as hypertension and diabetes further exacerbate LLD.LLD is a multifactorial disorder involving complex interactions among neurobiological systems. Effective prevention and management require an integrated, multidisciplinary approach that considers inflammation, genetics, neurotransmission, and brain structure alterations.